Tanfanercept (HL036)

tanfanercept · HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tanfanercept (HL036), covering 2024-05-31 to 2024-05-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease [Phase 3]